|
Reports Critical NEWS ALERTS -- Revolutions Medical (OTCBB: RMCP), Intellect Neurosciences, Inc. (OTCBB: ILNS), EcoBlu Products, Inc. (OTCBB: ECOB), CrowdGather (OTCBB: CRWG): Sign-Up for our FREE Stock Alerts TODAY!
(M2 PressWIRE Via Acquire Media NewsEdge) www.OTCtipReporter.com Reports Critical NEWS ALERTS -- Revolutions Medical (OTCBB: RMCP), Intellect Neurosciences, Inc. (OTCBB: ILNS), EcoBlu Products, Inc. (OTCBB: ECOB), CrowdGather (OTCBB: CRWG)
Sign-Up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at HYPERLINK "http://www.OTCtipReporter.com/" www.OTCtipReporter.com
_____________________________________________________________________________
Visit: www.OTCtipReporter.com
Revolutions Medical Corporation Announces Final Vetting Process for Initial Worldwide Distributors of Its RevVac Safety Syringe
CHARLESTON, S.C., Sept. 1, 2010 -- Revolutions Medical ("Revolutions Medical" or the "Company") (OTCBB: RMCP) is entering the final stage of the process to determine its initial global distributors. Since receiving FDA clearance for its RevVac safety syringe, the Company has received numerous inquiries to distribute its product. The potential future distributors have been narrowed down to a pool of just under 50 distributors. Over the next several weeks, the Company will be sending out market samples, confirming interest and commitments, and signing distribution agreements covering certain countries and regions, as well as global licensing agreements.
Tom O'Brien, President of Revolutions Medical stated, "The market demand for our RevVac Safety Syringe and the significant interest from global distributors is comparable to other revolutionary product releases that I have experienced over the course of my long career. The fact that we should be able to save lives and bring down the cost of health care by the implementation of our Safety Syringe, makes me very proud to be an integral part of our product roll out."
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac safety syringe (FDA approved), safety blood drawing device and safety IV catheter. The Company also provides RevColor, RevDisplay and Rev3D -- software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite's functionality includes sorting of images, color, 3D and automatic segmentation of images.
For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com
Investor Resource Center
RevVac Safety Syringe Demonstration Video: http://www.revolutionsmedical.com/videos/revac_directions_final.wmv
RevColor MRI Video: http://www.revolutionsmedical.com/RevMed-ColorMRI-Video.php
To be added to the Company's investor email list, please email Skey@revolutionsmedical.com with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook - visit http://www.Facebook.com/Revmed
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.
Follow our News and Alerts with our newsletter sign up today: http://www.OTCtipReporter.com
_____________________________________________________________________________
Visit: www.OTCtipReporter.com
Intellect Neurosciences to Participate in Rodman & Renshaw 2010 Annual Global Investment Conference in New York on September 14, 2010
NEW YORK, Sept. 1, 2010 -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage trials to treat and prevent Alzheimer's disease (AD), has announced that Daniel G. Chain, Ph.D., the company's chief executive officer and chairman of the board, will speak at the Rodman & Renshaw Annual Global Investment Conference in New York City on September 14, 2010
(http://www.rodmanandrenshaw.com/conferences?id=51). His presentation is scheduled to begin at 5:45pm EDT in the Garrison Salon (5th Floor) of the New York Palace Hotel.
About Intellect Neurosciences, Inc.
Intellect Neurosciences, Inc. is a Manhattan-based biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and other disorders. The Company's drug product pipeline includes OX1, which has been tested in Phase 1 clinical trials; IN-N01, a humanized monoclonal antibody designed to promote the clearance of soluble amyloid beta; and RECALL-VAX, a vaccine technology that has the potential to delay or prevent Alzheimer's disease in people who are at risk.
The Company has significant intellectual property assets, which include several patent families underlying the Company's internal programs, and a pivotal patent estate regarding passive AD immunotherapy.
The Company's ANTISENILIN patent estate claims monoclonal antibodies that bind either end of amyloid beta but do not interact with the amyloid precursor protein from which amyloid beta is produced in the body. This high degree of specificity is an important safety feature reducing the potential for adverse affects. Examples of monoclonal antibodies exhibiting this property are Bapineuzumab and Ponezumab in Alzheimer's Phase 3 and Phase 2 clinical trials, respectively (http://clinicaltrials.gov/ct2/show/NCT00574132?term=bapineuzumab&rank=1; http://clinicaltrials.gov/ct2/results?term=PF-04360365).
Patents have been granted in Europe, Japan, China and elsewhere, and are pending in the United States. Intellect has granted royalty-bearing licenses to its ANTISENILIN patent estate to several top tier global pharmaceutical companies developing monoclonal antibodies for Alzheimer's disease. For further information, see the Company's filings with the Securities and Exchange Commission, including Forms 8-K filed on:
May 1, 2009 http://www.sec.gov/Archives/edgar/data/1337905/000114420409023426/v147731_8k.htm
January 8, 2009 http://www.sec.gov/Archives/edgar/data/1337905/000114420409000980/0001144204-09-000980-index.htm
October 14, 2008 http://www.sec.gov/Archives/edgar/data/1337905/000114420408057464/0001144204-08-057464-index.htm
May 19, 2008 http://www.sec.gov/Archives/edgar/data/1337905/000114420408030722/v115138_8k.htm
Safe Harbor Statement Regarding Forward-Looking Statements
The statements in this release and oral statements made by representatives of Intellect relating to matters that are not historical facts (including without limitation those regarding future performance or financial results, the timing or potential outcomes of research collaborations or clinical trials, any market that might develop for any of Intellect's product candidates and the sufficiency of Intellect's cash and other capital resources) are forward-looking statements that involve risks and uncertainties, including, but not limited to, the likelihood that actual performance or results could materially differ, that future research will prove successful, the likelihood that any product in the research pipeline will receive regulatory approval in the United States or abroad, or Intellect's ability to fund such efforts with or without partners. Intellect undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly any forward-looking statements should be read in conjunction with the additional risks and uncertainties detailed in Intellect's filings with the Securities and Exchange Commission, including those factors discussed under the caption "Risk Factors" in Intellect's Annual Report on Form 10-K, (file no. 333-128226) filed on October 13, 2009, and Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2010, filed on May 17, 2010.
Follow our News and Alerts with our newsletter sign up today: http://www.OTCtipReporter.com
_____________________________________________________________________________
Visit: www.OTCtipReporter.com
Home Builders' New Perspective on Sustainability
EcoBlu Products and Heritage Building and Development Featured on NBC News
VISTA, Calif., Sept. 2, 2010 -- EcoBlu Products, Inc. (OTCBB:ECOB) announced today that one of its development partners, Heritage Building and Development of San Diego, was featured on the local NBC 7/39 evening news. Heritage completed the framing of 3 model homes, all using EcoBlu's BLUWOODPlus technology in the planned community of Otay Ranch in Chula Vista, California. The feature story touted the progressive thinking of Heritage Building providing EcoBlu protection to their customers and still maintaining a competitively priced product in today's market conditions.
The news broadcast can be viewed at http://www.youtube.com/ecobluproducts
"Heritage is a production home builder in San Diego County and we are thrilled that they chose to use BLUWOODPlus for this project," said Steve Conboy, President and CEO of EcoBlu Products. "Outside the box thinking is leading the way for other builders to see the real benefits of BLUWOOD technology for homeowners and a sustainable environment," added Conboy.
Otay Ranch is a 5,300 acre pedestrian friendly planned community. Since its opening in 1999, Otay Ranch has been San Diego County's top selling planned community quarter after quarter.
About EcoBlu Products, Inc.
EcoBlu Products, Inc. is a manufacturer of proprietary wood products coated with an eco-friendly chemistry that protects against mold, fungus, rot-decay, wood ingesting insects, termites and fire with EcoBlu's FRC technology (Fire Retardant Coating). EcoBlu products utilizing BLUWOOD and FRC technology is the ultimate in wood protection, preservation, and fire safety to building components constructed of wood; from joists, beams and paneling, to floors and ceilings.
The Company is committed to the development, marketing and sales of environmentally-responsible building materials. EcoBlu products are ready to deliver the winning edge to builders and the environment with its sustainable green product line.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: The statements in this release relating to completion of the acquisition and the positive direction are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include, but are not limited to, contractual difficulties which may arise, the failure to obtain necessary approvals, the future market price of EcoBlu Products, Inc. common stock and the ability to obtain the necessary financing.
Follow our News and Alerts with our newsletter sign up today: http://www.OTCtipReporter.com
____________________________________________________________________________
Visit: www.OTCtipReporter.com
CrowdGather, Inc. Announces Near-Term Revenue Guidance and Corporate Update
WOODLAND HILLS, Calif. -- 09/02/2010 -- One of the leading networks of forum communities on the Internet, CrowdGather (OTCBB:CRWG), today announced that it expects to record approximately $330,000 in revenues for the company's 2011 fiscal first quarter ended July 31st, 2010. Additionally, management anticipates an increase in revenues to approximately $430,000 for the current 2011 fiscal second quarter which will end October 31st, 2010. The Company is experiencing steady growth, but is not yet profitable. While CrowdGather has reported sequentially increased revenues for every quarter since it went public in April, 2008, there can be no assurance that this trend will continue since there is some seasonality to Internet advertising rates and demand that may result in seasonal variance. These are unaudited results which are being provided in response to shareholder queries based upon recent market conditions and global economic uncertainties.
CrowdGather is also pleased to provide the following corporate updates regarding the Company's growth in the past calendar year:
* Traffic to the CrowdGather network of sites during this calendar year has increased 750%, from approximately 12 million monthly pageviews to approximately 90 million pageviews. The Company's sites currently enjoy approximately 4.5 million unique visitors per month.
* CrowdGather has closed $6.5 million in all stock acquisitions through the purchase of digital advertising agency, Adisn and the purchase of the forum technology assets of Lefora.
* Company is debt-free having strengthened its balance sheet through the voluntary conversion by investors of approximately $2.5 million in outstanding debt and accrued interest from prior financing transactions into equity.
* CrowdGather experienced a significant reduction of its shares outstanding due to the cancellation of 5 million shares of CEO, Sanjay Sabnani's beneficial holdings in CrowdGather as part of the convertible debt conversion. The Company currently has 45,826,679 shares outstanding.
* Within this year, CrowdGather has raised approximately $1.5 million in equity financing and working capital through private placements and exercise of outstanding warrants by previous investors.
"Our soon to be announced record fiscal first quarter results will hopefully demonstrate that recent acquisitions and increased network traffic have had a direct impact on our revenues," said Sanjay Sabnani, CrowdGather's Chairman and CEO. "Based upon our analysis, we have achieved revenues in the first quarter of this year that exceed what we did in the entire prior 12 month period. Furthermore, we believe we are on track to exceed even this increase in the current quarter."
About CrowdGather, Inc.
With its growing portfolio of special interest forums and enthusiast message board communities, CrowdGather (www.crowdgather.com) has created a centralized network to benefit forum members, forum owners and forum advertisers. CrowdGather provides a highly interactive and informational social network for members, a management and revenue-sharing resource for third-party forum owners, and a largely untapped advertising network for marketers worldwide.
This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events and the Company's growth and business strategy. Words such as "expects," "will," "intends," "plans," "believes," "anticipates," "hopes," "estimates," and variations on such words and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, changes in the Company's business; competitive factors in the market(s) in which the Company operates; risks associated with operations outside the United States; and other factors listed from time to time in the Company's filings with the Securities and Exchange Commission. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
Follow our News and Alerts with our newsletter sign up today: http://www.OTCtipReporter.com
_____________________________________________________________________________
Visit: www.OTCtipReporter.com
About OTCtipReporter.com
www.OTCtipReporter.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.
www.OTCtipReporter.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity. To subscribe to this free service, visit the OTCtipReporter Stock Report home page at http://www.OTCtipReporter.com and Sign up Free For "Daily Stock Alerts".
Join us at http://www.OTCtipReporter.com for a complimentary subscription to the most exciting online financial newsletter on the market.
Disclaimer: Verify all claims and do your own due diligence. OTCtipReporter.com profiles are not a solicitation or recommendation to buy, sell or hold securities. OTCtipReporter.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. OTCtipReporter.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), OTCtipReporter.com is owned and operated by OTCtipReporter.com. Neither OTCtipReporter.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this press-release, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since OTCtipReporter.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in OTCtipReporter.com statements and opinions and such statements and opinions cannot be considered independent. OTCtipReporter.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. OTCtipReporter.com services are often paid for using free-trading shares. OTCtipReporter.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Visit us for a full Disclaimer at: http://www.otctipreporter.com/disclaimer.asp
((Comments on this story may be sent to info@m2.com))
(c) 2010 M2 COMMUNICATIONS
[ Back To Contact Center Solutions Homepage's Homepage ]
|
NextiraOne Obtains Cisco's Unified Contact Centre Enterprise ATP Status 
SVP Ireland minimises administration costs and will benefit from returns on investment with integrated system from m-hance
NEW Consolidating Infrastructures: IT's New Call to Business [white paper]
